Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — A blood cancer treatment from GSK helped patients live longer in ...
GSK plc has announced that GSK5764227 (GSK'227), its B7-H3-targeted antibody-drug conjugate (ADC), has received Orphan Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback